The Staphylococcus aureus transpeptidase sortase A (SrtA) is responsible for anchoring a range of virulence-and colonizationassociated proteins to the cell wall. SrtA recognizes substrates that contain a Cterminal LPXTG motif. This sequence is cleaved following the threonine, and an amide bond is formed between the threonine and the pentaglycine cross-bridge of branched lipid II. Previous studies have implicated the 6/ 7 loop region of SrtA in LPXTG recognition, but have not systematically characterized this domain. To better understand the individual roles of the residues within this loop, we performed alanine-scanning mutagenesis. Val168 and Leu169 were found to be important for substrate recognition, and Glu171 was also found to be important, consistent with its hypothesized role as a Ca 2+ -binding residue. Gly167 and Asp170 were dispensable for catalysis, as was Gln172. The role of Arg197 in SrtA has been the subject of much debate. To explore its role in catalysis, we used native chemical ligation to generate semi-synthetic SrtA in which we replaced Arg197 with citrulline, a nonionizable analog. This change resulted in less than a 3-fold decrease in k cat /K M , indicating that Arg197 utilizes a hydrogen bond, rather than an electrostatic interaction. Our results are consistent with a model for LPXTG recognition wherein the Leu-Pro sequence is recognized primarily by hydrophobic contacts with SrtA Val168 and Leu169, as well as a hydrogen bond from Arg197. This model contradicts the previously proposed mechanism of binding predicted by the X-ray crystal structure of SrtA.
The Staphylococcus aureus transpeptidase sortase A (SrtA) is responsible for anchoring a range of virulence-and colonizationassociated proteins to the cell wall. SrtA recognizes substrates that contain a Cterminal LPXTG motif. This sequence is cleaved following the threonine, and an amide bond is formed between the threonine and the pentaglycine cross-bridge of branched lipid II. Previous studies have implicated the 6/ 7 loop region of SrtA in LPXTG recognition, but have not systematically characterized this domain. To better understand the individual roles of the residues within this loop, we performed alanine-scanning mutagenesis. Val168 and Leu169 were found to be important for substrate recognition, and Glu171 was also found to be important, consistent with its hypothesized role as a Ca 2+ -binding residue. Gly167 and Asp170 were dispensable for catalysis, as was Gln172. The role of Arg197 in SrtA has been the subject of much debate. To explore its role in catalysis, we used native chemical ligation to generate semi-synthetic SrtA in which we replaced Arg197 with citrulline, a nonionizable analog. This change resulted in less than a 3-fold decrease in k cat /K M , indicating that Arg197 utilizes a hydrogen bond, rather than an electrostatic interaction. Our results are consistent with a model for LPXTG recognition wherein the Leu-Pro sequence is recognized primarily by hydrophobic contacts with SrtA Val168 and Leu169, as well as a hydrogen bond from Arg197. This model contradicts the previously proposed mechanism of binding predicted by the X-ray crystal structure of SrtA.
The increasing prevalence of multi-drug resistant Gram-positive bacterial infections has been a cause for great concern (1, 2) . Most alarming has been the recent characterization of strains of Staphylococcus aureus which exhibit either intermediate or full resistance to vancomycin, currently the antibiotic of last resort for MRSA infections (3) (4) (5) . During pathogenesis, Gram-positive bacteria use virulence factors to aid in adherence to host endothelial tissues, evasion of the immune system, and the acquisition of iron from the local environment (6, 7) . There has been a great deal of recent interest in the idea of targeting these virulence factors as a possible strategy for the development of new therapeutics for the treatment of Gram-positive infections (8, 9) .
Sortases are cysteine transpeptidase enzymes found in a wide-range of Grampositive pathogens. They catalyze the formation of a covalent linkage between surface proteins containing an LPXTG motif and the peptidoglycan layer of the cell wall (6) . Many of these cell-wall anchored proteins function as virulence factors (6, 10) .
As such, several previous studies have implicated a role for sortases in promoting virulence in several strains of Gram-positive bacteria. Sortase knock-out strains have been shown to have reduced pathogenicity in Staphylococcus aureus (11) , Listeria monocytogenes (12, 13) , and in several members of the Streptococcus lineage: S. gordonii (14), S. pneumonia (15) , S. pyogenes (16) , S. mutans (17) , S. suis (18) , S. sanguinis (19) , and S. agalactiae (20) .
In Staphylococcus aureus, the majority of surface proteins are anchored by the action of sortase A (SrtA). SrtA recognizes substrates that contain a C-terminal cell-wall sorting motif 2 consisting of a conserved LPXTG motif, followed by a hydrophobic domain, and a positively-charged tail (21, 22) . The enzyme catalyzes cleavage of the LPXTG motif between the threonine and glycine residues by means of an active-site cysteine (Cys184) (23) . This leads to the formation of a covalent acyl-enzyme intermediate, which is then resolved by nucleophilic attack from the amino group of the Gly 5 cross-bridge on branched lipid II, a peptidoglycan precursor (24, 25) . Subsequent transglycosylation and transpeptidation reactions incorporate the protein-linked lipid II into the mature cell wall.
Although the substrate specificity requirements of SrtA have been well documented (26, 27) , the exact molecular basis for this specificity remains unclear. Several recent studies have implicated the 6/ 7 loop region of SrtA in LPXTG recognition (28) (29) (30) . However, these studies have not systematically explored the roles of the individual residues within the 6/ 7 loop, and have not directly established which residues are critical for LPXTG recognition.
Much debate has occurred in the literature over the role of a conserved active-site arginine residue (Arg197) in SrtA catalysis. It has been suggested that Arg197 may function as a general base, helping to deprotonate either Cys184 or the incoming Gly 5 chain on branched lipid II (31, 32) . Alternatively, it has been suggested that Arg197 may play a role in stabilizing the formation of an oxyanion transition state prior to formation of the acyl-enzyme intermediate (28, 33) . A recent study by Frankel et al. provided evidence against the first interpretation, and suggested that the role of Arg197 was in transition-state stabilization (33) . However, this study was unable to discriminate whether Arg197 acts via an electrostatic interaction or through a side-chain hydrogen bond interaction.
In order to better understand the determinants of substrate specificity and LPXTG recognition in SrtA, we have performed alaninescanning mutagenesis of six key residues along the 6/ 7 loop in SrtA. In addition, we have used native chemical ligation to generate a synthetic amino acid mutant of Arg197, by replacing the arginine with a citrulline. We have characterized these mutants biophysically, and we report here the results of the mutations on the kinetic parameters k cat and K M of SrtA. Finally, we have developed a revised model for substrate recognition and catalysis in SrtA, and discuss implications for future studies.
EXPERIMENTAL PROCEDURES
General. Buffer salts were purchased from Sigma (St. Louis, MO).
Oligonucleotide primers were purchased from Integrated DNA Technologies, Inc. (Coralville, IA), and were used without further purification. The pTWIN1 vector was purchased from New England Biolabs (Ipswich, MA).
Escherichia coli electrocompetent DH5 cells (Invitrogen) and E. coli BL21(DE3) electrocompetent cells (Novagen) were used according to the manufacturer's recommendations. Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs. DNA sequencing was performed at the Duke University DNA Analysis Facility. Standard Fmoc-protected amino acids (Novabiochem), NH 2 -Gly 5 -OH (Bachem), Boc-Abz-OH (Bachem), and FmocDap(DNP)-OH (Bachem), were purchased and used without further purification. 5-(4-Fmocaminomethyl-3,5-dimethoxyphenoxy)valeric acid-MBHA (PAL) resin was purchased from Advanced Chemtech. Fmoc-Lys(Boc)-Wang resin was purchased from Bachem, and used without further purification. Solid-phase peptide synthesis was performed on an Applied Biosystems 433A peptide synthesizer. Protein purification was performed on an AKTA fast protein liquid chromatography system equipped with a UV detector (GE Healthcare). Preparative-scale HPLC was performed on a Rainin HPXL series system equipped with a Dynamax UV-1 detector, and a preparative (50 x 250 mm, 10-15 µm) C8 column (Vydac, Inc.). Analytical HPLC was performed on an Agilent 1200 series HPLC equipped with an autosampler, fraction collector, diode array UV detector, fluorescence detector, and a fast analytical (4.6 x 50 mm, 3 µm) C18 column (Vydac, Inc.). MALDI-TOF mass spectrometry was performed using a Voyager™ mass spectrometer (Applied Biosystems). ESI mass spectrometry was performed on an Agilent 1100 series LC/MSD ion trap mass spectrometer, in positive ion mode.
Cloning of SrtA N24 constructs. The plasmid pET15bSrtA N24 (27) was used as a template. Primer pairs pTWIN1SrtA N24 fwd and pTWIN1SrtA full rev (see Table 1 for sequences) were used to PCR amplify the sequence of SrtA out of this vector, and primer pairs pTWIN1SrtA N24 fwd and pTWIN1SrtA trunc rev (see Table 1 ) were used to PCR amplify the sequence of SrtA . In each case, the resulting DNA fragments were gel-purified, double digested with NdeI and SapI, then ligated with T4 DNA ligase into vector pTWIN1 which had been previously digested with the same enzymes, generating the plasmids pTWIN1SrtA and pTWIN1SrtA , respectively. DNA sequencing was used to confirm that the desired sequence had been generated. The final plasmids each contained the desired SrtA sequence, fused in-frame at the C-terminus to the GyrA intein from Mycobacterium xenopi and a chitin-binding domain.
Site-directed mutagenesis. The plasmid pTWIN1SrtA was used as a template for the introduction of single amino-acid substitutions by PCR, using the QuikChange® method (Stratagene, Inc.). The forward and reverse primer pairs used to generate each of the discussed SrtA mutants are listed in Table 1 . Successful mutations were confirmed by DNA sequencing.
Expression, Purification of SrtA and mutants. The plasmid pTWIN1SrtA was transformed by electroporation into E. coli BL21(DE3) cells. The cells were grown at 37°C in LB media containing 100 µg/mL of Ampicillin. When the OD 600 reached 0.5-0.6, expression was induced with 1 mM isopropyl -D-thiogalactopyranoside (IPTG), and the cells were grown for an additional 3 h at 37°C, then were harvested by centrifugation at 3000 x g for 10 min. Cells were resuspended in buffer A (100 mM sodium phosphate, 500 mM NaCl, pH 7.0), and lysed with an EmulsiFlex-C5 high pressure homogenizer (Avestin, Inc.). The lysate was centrifuged for 45 min at 30,000 x g, and the supernatant was applied to a column of chitin-beads (New England Biolabs) which had been pre-equilibrated with buffer A. The flowthrough from the loading step was reapplied to the column, which was then washed with 250 mL of buffer A. Cleavage of the intein and elution of the target protein were induced by overnight recirculation (using a peristaltic pump) of buffer B (100 mM sodium phosphate, 500 mM NaCl, 40 mM DTT, pH 7.0). Fractions of flow-through from the overnight recirculation were collected and 20 µL aliquots from each step and fraction were analyzed by SDS-PAGE. SrtA -containing fractions were concentrated to a volume of 12 mL using an Amicon stirred ultrafiltration cell (Millipore, Inc.) with a 5,000-NMWL filter. The concentrated protein sample was then loaded onto a HiPrep 26/60 Sephacryl S-200 gel filtration column (GE Healthcare) which had been pre-equilibrated with buffer D (150 mM NaCl, 50 mM Tris, 5 mM CaCl 2 , 0.1% -mercaptoethanol, 10% glycerol, pH 7.5), and the column was run overnight. 5 mL fractions were collected, and 20 µL aliquots of these were analyzed by 12% SDS-PAGE.
Fractions containing pure SrtA were pooled, then concentrated to at least 150 µM using a combination of Amicon stirred ultrafiltration cells (with a 5,000-NMWL membrane) and Amicon ultra centrifugal filters (5,000-NMWL membrane).
Protein concentration was determined spectrophotometrically, using the extinction coefficient 280 = 17,420 M -1 cm -1
(same 280 for all SrtA mutants). Protein molecular weight was verified by ESI-MS. Multiply-charged ion states were detected, and software was used to deconvolute the spectra and obtain an accurate molecular weight for the protein (error 0.01%). All mutants (except R197Cit) were generated via the same methods.
Expression and purification of SrtA protein-thioester. The plasmid pTWIN1SrtA was used for protein expression as described above for pTWIN1SrtA , and crude protein was loaded onto a column of chitin-beads. Following the wash step, the protein-thioester SrtA -MESNA was eluted by overnight recirculation of buffer C (100 mM sodium phosphate, 500 mM NaCl, 100 mM MESNA, pH 7.0). Fractions of flow-through from the overnight recirculation were collected and 20 µL aliquots were analyzed by 12% SDS-PAGE. Fractions containing SrtA -MESNA were by guest on November 19, 2017 http://www.jbc.org/ Downloaded from pooled, then purified by preparative-scale HPLC on a C8 column, using a linear gradient from 22-41% acetonitrile/0.1% trifluoroacetic acid. Purified SrtA -MESNA from multiple injections was pooled, then lyophilized to dryness. Product composition was determined by MALDI-TOF MS (MW = 18267.6 Da).
Solid-phase synthesis of peptides. Peptides corresponding to the C-terminal 23 residues of SrtA (residues 184-206) were synthesized by the Fmoc/piperidine strategy on preloaded FmocLys(Boc)-Wang resin on a 0.25-mmol scale. The SrtA substrate peptide Abz-LPETGGDap(DNP)-NH 2 was synthesized using the Fmoc/piperidine strategy on PAL resin at 0.25-mmol scale. Peptides were synthesized and purified using previously established methods (27, 30) . Purified peptides were lyophilized to dryness, and product identities were confirmed by MALDI-TOF MS.
Generation of semi-synthetic SrtA -MESNA was combined with 27.6 mg of SrtA in a 20 mL scintillation vial with a rubber septum top. The vial was sealed, purged of oxygen, and kept under argon atmosphere.
Degassed NCL reaction buffer (5 mL, of 6 M GuHCl, 100 mM sodium phosphate, 20 mM TCEP, 100 mM MPAA, pH 7.0) was added to the vial with a syringe, and the reaction was allowed to proceed under argon atmosphere at 40°C. Final concentrations of the reactants were 450 µM SrtA -MESNA and 2.0 mM SrtA . Aliquots (10 µL) of the reaction mix were removed every hour and analyzed by reverse phase HPLC; the reaction was judged to be nearly complete after 8 h. The product SrtA was purified by reverse phase HPLC, using a preparative scale Jupiter™ C8 column (Vydac, Inc.), with a gradient from 22-45% Acetonitrile/0.1% Trifluoroacetic acid. Pooled reaction products were lyophilized to dryness. The resulting powder was resuspended in 8 mL of buffer E (25 mM sodium phosphate, pH 5.8), and incubated on ice for 4 h to re-fold. The resulting solution was applied to a SP Sepharose fast-flow column which had been preequilibrated with buffer E. SrtA was eluted from the column using buffer E with a gradient from 0 to 500 mM NaCl. 6 mL fractions were collected, and 20 µL aliquots of these were analyzed by 12% SDS-PAGE. Fractions containing pure SrtA were pooled and concentrated to 8 mL volume using an Amicon stirred ultrafiltration cell with a 5,000-NMWL membrane. The concentrated protein solution was dialyzed overnight at 4°C against buffer D, using a Slide-A-Lyzer dialysis cassette with a 5,000-NWML membrane (Pierce, Inc.). Recovered protein was concentrated to at least 100 µM using an Amicon ultra centrifugal filter (5,000-NMWL membrane).
Protein concentration was determined spectrophotometrically using the extinction coefficient 280 = 17,420 M -1 cm -1 . The mutant protein SrtA R197Cit was made in the same manner, except that the peptide SrtA (184-206) R197Cit was used. The final molecular weights of both semi-synthetic proteins were verified by ESI-MS.
Thermal stability studies using circular dichroism spectroscopy. Aliquots (300 µL) of concentrated protein were dialyzed overnight at 4°C against buffer containing 10 mM Tris (pH 7.5), 30 mM NaCl, and 5 mM CaCl 2 . Samples were diluted in the same buffer until final protein concentrations were 5 µM. Protein concentrations of the diluted solutions were obtained spectrophotometrically, using the extinction coefficient 280 = 17,420 M -1 cm -1
(same for all proteins). For each protein, 2 mL was transferred to a quartz cuvette with a 1 cm path length for CD data collection. CD spectra were measured on an Aviv Instruments model 202 Circular Dichroism spectrometer. An initial wavelength scan was taken for recombinant SrtA , at 25°C, from 260 to 190 nm in 1-nm steps, with a scanning speed of 4 sec/nm. Two scans were taken and were averaged and corrected for background absorbance. For thermal denaturation studies, 2 mL samples were transferred to a quartz cuvette with a 1 cm path length, and CD spectra were collected at 216 nm, in 2°C steps from 4 to 98°C. Samples were equilibrated for 30 sec at each temperature prior to data collection, and the average CD signal at 216 nm was collected over a 20 sec window. The observed signal was corrected for background absorbance, and ‡ where obs represents the observed ellipticity in degrees, c is the protein concentration in M, d is the optical path length in cm, and n is the number of amino acid residues in the protein (182 in all cases).
HPLC assays for SrtA activity. SrtA activity was measured using the HPLC-based assay described by Kruger et al. (37) . For initial activity determinations, wild-type recombinant SrtA (1 µM) and mutant enzymes (varying concentrations, ranged from 1 µM to 100 µM) were incubated with peptide substrates Abz-LPETGG-Dap(DNP)-NH 2 (1.5 -2.0 mM) and NH 2 -Gly 5 -OH (2 mM). The substrate Abz-LPETGG-Dap(DNP)-NH 2 was used in place of the more typical Abz-LPETG-Dap(DNP)-NH 2 , because a recent study showed that SrtA more rapidly turns over substrates containing a glycine in the P2' position (38) . Reactions were performed in a 100 µL volume in standard assay buffer (150 mM NaCl, 5 mM CaCl 2 , 300 mM Tris-Cl, pH 7.5). Assays were initiated by addition of enzyme, and were run for anywhere between 15 min and 6 h at 37°C, depending upon the activity levels. At each timepoint assays were quenched by removal of 80 µL of reaction mix into 40 µL of 1.2 M HCl and analyzed by HPLC.
To determine kinetic parameters for each of the mutants, assay lengths and enzyme concentrations were chosen so as to approximate the levels of activity observed for wild-type recombinant SrtA during a 7.5 min assay. Volumes of enzyme solution added to each reaction were kept below one-tenth of total assay volume.
Linearity of SrtA activity was established for all of the mutants by monitoring product formation as a function of time during the assay window. Enzyme concentrations and assay lengths for kinetic analysis of each mutant SrtA were as follows: wild-type (semisynthetic), 1 µM for 7.5 min; R197Cit, 1 µM for 20 min; R197A, 50 µM for 2.5 h; R197K, 50 µM for 2.5 h; G167A, 1 µM for 10 min; V168A, 1 µM for 75 min; L169A, 10 µM for 2 h; D170A, 1 µM for 10 min; E171A, 1 µM for 75 min; Q172A, 1 µM for 15 min.
Abz-LPETGG-Dap(DNP)-NH 2 was varied from 61 µM to 13.15 mM, and the resulting data was fit to the Michaelis-Menten equation for steady-state kinetics using SigmaPlot v.8.0 (SPPS, Inc.), to obtain estimates for the kinetic parameters k cat and K M . The change in free energy of the transition state for mutants was estimated from Equation 2:
where G ‡ is the change in free energy of the transition state between wild-type (WT) and mutant (Mut), R is the ideal gas constant and T is temperature.
Modeling studies. In order to perform comparative analysis, the 1.8 Å resolution X-ray structure of the LPETG-bound mutant SrtA N59 C184A was selected (PDB: 1T2W). This structure was solved in the absence of Ca 2+ . There were three molecules in the asymmetric unit of this structure. Model A was chosen for analysis, since this was the only model which crystallized with a bound LPETG peptide. Residue Ala184 was replaced in silico with a cysteine, and the Cys184 side chain was modeled based on its orientation in the wild type SrtA N59 structure.
RESULTS

Mutagenesis of the 6/ 7 loop in SrtA.
The recently solved X-ray crystal structure of SrtA N59 (28) has served as a useful guide for understanding substrate recognition in SrtA, but it has also left many questions unanswered. In particular, the role of the 6/ 7 loop in LPXTG recognition has remained a mystery. Several lines of evidence suggest a role for this domain in initial substrate recognition (28) (29) (30) 39) . First, it is located at the posterior of the active site cavity, in a position above the N-terminal ends of the 4 and 7 strands and above the Cterminal end of the 8 strand (see Figure 1) . The 6/ 7 loop is thus in an ideal position to interact with the leucine-proline at the Nterminal end of the LPXTG sorting signal, facilitating recognition. Second, the loop has been shown to be highly flexible in solution, but becomes ordered upon calcium binding (29) . The binding of calcium (which stimulates SrtA activity 8-fold) thus "locks" the loop into the correct conformation to allow for LPXTG binding and cleavage. Third, this loop domain differs between SrtA and SrtB, which recognizes an NPQTN sorting signal. It was shown recently that swapping the 6/ 7 loop from SrtB into SrtA was sufficient to alter the specificity of SrtA by over 700,000-fold, directly implicating this loop in substrate discrimination (30) .
While a role for the 6/ 7 loop of SrtA in LPXTG recognition appears clear, the mechanism by which it does this remains somewhat murky. Since it is highly flexible, it has been very difficult to obtain precise structural information about the residues which make up the loop. In the 2.0 Å X-ray crystal structure of SrtA N59 (28) , there were three molecules in the asymmetric unit, and the 6/ 7 loop took on a different conformation in each molecule. While the overall RMSD for thecarbons between the three molecules was only 0.5 Å, across the 6/ 7 loop it wais 4.1 Å. Similarly, in the 1.8 Å crystal structure of SrtA N59 C184A (28) with an LPETG peptide bound, three molecules crystallized in the asymmetric unit, and again, in each molecule the loop took on a different conformation. RMSD for the -carbons overall was 0.6 Å, but for the 6/ 7 loop it was 2.8 Å. The average B-factors for the residues in this loop were extremely high (ranging from 91 to 136.9), and it was not possible to model the loop in two of these six models. NMR studies have shown that the loop becomes much more ordered upon the binding of a single calcium ion, implicating a role for the loop in adaptive recognition of the LPXTG substrate (29, 39) . However, the exact set of residues utilized for substrate binding and cleavage remain unclear.
In order to better understand the importance of residues within the 6/ 7 loop for substrate recognition, structural analysis was performed. Based on the X-ray structure of LPETG-bound SrtA N59 C184A (28), we identified residues Gly167-Asn172 as potential recognition sites for LPXTG (see Figure 1) . Specifically, this model suggested that residues Val168 and Leu169 would be important, via hydrophobic interactions, for recognition of the hydrophobic Leu-Pro segment of the sorting signal. Asn172 was also predicted to be important, based on a potential hydrogen bond interaction between the side chain of Asn172 and the backbone carbonyl and amide of Leu-Pro in the crystal structure.
To test our predictions we performed alanine-scanning mutagenesis. Six site-specific amino acid mutants were generated, replacing each residue (Gly167-Asn172) in turn with an alanine.
Each mutant was successfully expressed in E. coli BL21(DE3) cells and was purified to 98% purity as judged by SDS-PAGE (data not shown).
Thermal stability measurements of 167-172 mutants. To explore the effects of the alanine mutations on the stability of SrtA, we used Circular Dichroism spectroscopy to compare the thermal stabilities of the variant proteins with that of wild-type SrtA. While the overall CD spectrum of SrtA does not show strong features (data not shown), the protein has been shown to be active under the conditions used for CD, and is assumed to be properly folded (33) . Importantly, the observed CD signal changes both in intensity and in shape when heatdenatured, and CD has thus been validated as a tool to monitor global unfolding of this protein.
For our studies, we chose to observe the CD signal at 216 nm ( 216 ), since the wild-type protein gives a strong negative signal at this wavelength, and this signal is altered upon heating to 98°C. In order to measure the thermal stability of our mutants, measurements of 216 were made over the range of 4 to 98°C, and fit using a 4-parameter sigmoidal fit to obtain estimates for T m . The results are shown in Figure 2 . No changes were observed in either the T m or the onset of unfolding for any of our variants, indicating that the global stability of the protein is not altered by these mutations. Although the possibility of more subtle effects on local stability cannot be ruled out, these results argue that the overall structures of the mutated proteins remain unaffected.
Steady-state kinetics of 167-172 mutants. Once the stability of the mutants had been established, enzymatic assays were performed to explore the effects of the mutations on catalytic activity.
Steady-state analysis allowed for estimation of the kinetic parameters k cat and K M for each protein. A summary of the observed kinetic parameters is shown in Table 3 .
For the mutants G167A and D170A, no change in the kinetic parameters was observed. Indeed, for these variants both k cat and K M were within experimental error of the values for wildtype enzyme, suggesting that these residues do not play a role in substrate recognition or catalysis.
By contrast, mutation of either Val168 or Leu169 to alanine was detrimental to catalysis. The mutations caused a 7.3-fold and an 89-fold decrease in k cat , respectively. Interestingly, in both cases the value of K M was unchanged from the wild-type. Loss of a substrate-binding residue would normally be expected to cause an increase in K M , yet that is not observed here. The 93-fold decrease in k cat /K M observed for the L169A mutant is larger than those seen for individual mutations within the active-site 7 strand itself, and is the largest observed for a non-catalytic residue (33) . While the effects of the Val168 and Leu169 mutations are confined to k cat , this does not rule out a role for these residues in substrate recognition. A recent study showed that k cat effects on specificity can be observed in enzymes that require a conformational rearrangement to actively align catalytic residues prior to catalysis (40) , and such a rearrangement has been proposed for SrtA (28, 39) . It is possible that the roles of Val168 and Leu169 are more than a simple initial binding of LPXTG; instead, we theorize that they are responsible for positioning the substrate such that it is properly oriented for nucleophilic attack by the active-site Cys184.
Mutation of Glu171 to alanine resulted in a 6.9-fold decrease in k cat . A previous study has implicated this residue in calcium-binding, and thus the stabilization of the 6/ 7 loop (29). A potential calcium-binding site was identified, consisting of Glu171 and several residues on the 3/ 4 loop (Glu105, Glu108, Asp112, and Asn114). In that study, the authors observed a 4.8-fold decrease in k cat upon mutation of Glu171 to alanine, and our results are consistent with this. Calcium-binding has been shown to have a stimulatory effect on SrtA catalysis, increasing the rate of the enzyme by about 8-fold. The mutant E171A is impaired in catalysis by about the same amount. Given that mutation of Glu171 to alanine has previously been shown to reduce sensitivity to Ca 2+ (29) , the data collectively suggest that the effect of this mutation is to impair or abolish calcium-binding by the enzyme. If so, then the remainder of the 6/ 7 loop would remain highly flexible, preventing efficient substrate binding and cleavage. Interestingly, in the structural model of SrtA N59 C184A bound to LPETG, Glu171 is pointing out towards bulk solvent, away from both the peptide and the putative calciumbinding site (see Figure 1) . Our results, as well as those of the previous study (29) , argue that this cannot be the correct orientation for this residue.
Regarding Gln172, mutation to alanine has no effect on k cat , and only a negligible effect on K M , arguing against an important role for this residue in substrate recognition. In the LPETGbound structure of SrtA N59 C184A, this residue is pointing into the active site, and appears to be well-positioned to make one or two hydrogen bonds to the backbone of the Leu-Pro amide bond in the peptide. However, the kinetics of the mutant argue against the existence of such a hydrogen bond.
Mutagenesis of Arg197. In addition to residues along the 6/ 7 loop, a conserved arginine within the active site (Arg197) has been demonstrated to be important for catalysis (31) . While this residue has been shown to be important for LPXTG cleavage, its mechanism of action has been the subject of some controversy. Three distinct roles for this residue have been proposed: 1) that it acts as a general base, helping to deprotonate either Cys184 or the incoming secondary nucleophile (i.e. Gly 5 ) for catalysis (28, 31, 32) , 2) that it helps to stabilize the formation of an oxyanion-like transition state, via electrostatic interactions (28, 33) , or 3) that it utilizes a hydrogen bond interaction to bind to and orient the LPXTG substrate for catalysis (shown here). A previous study provided evidence arguing against the first possibility (33). The pH-rate profile of SrtA was found to be unaffected by mutation of Arg197 to alanine or lysine, suggesting that Arg197 does not participate in one of the important ionizations for catalysis (33) . However, an unanswered question is whether Arg197 acts primarily via electrostatic interactions or via specific hydrogen bond interactions with its side chain guanidino group.
Native chemical ligation to generate Arg197Cit mutant. To discriminate between these two possibilites, we generated a mutant protein where Arg197 was replaced by a citrulline residue (Figure 4) . Citrulline is an isosteric analog of arginine which differs only in the replacement of the guanidino group of arginine by a urea group in citrulline. It thus mimics closely the shape of arginine, and retains much of its hydrogen-bonding capability, as both residues contain a terminal -NH 2 group, which can act as a hydrogen-bond donor. Unlike arginine, citrulline does not carry a formal positive charge at neutral pH, and it cannot participate in electrostatic interactions. Several previous studies have shown that citrulline can be an effective mimic for arginine, and can be used to discriminate specific interactions (41) (42) (43) (44) (45) .
In order to generate the point-mutant R197Cit, we used the technique of native chemical ligation as described by Dawson et al. (34) . To maintain consistency in our results, we also made wild-type SrtA by this method. Hereafter, we will refer to fully-recombinant SrtA as "SrtA rec", and semi-synthetic SrtA as "SrtA syn", to avoid confusion. In addition to the R197Cit mutant, we also generated recombinant point-mutants R197A and R197K, for comparison.
Thermal stability of Arg197 mutants. All of the Arg197 mutants were initially evaluated for thermal stability by CD, as described above for the 6/ 7-loop mutants. Results of the CD denaturation studies are shown in Figure 2 . Neither the onset of unfolding nor the T m were affected by any of the mutations, indicating that the mutants remain folded.
Kinetics of Arg197 mutants. The kinetics for the Arg197 mutants are shown in Table 4 . Mutation of Arg197 to either alanine or lysine led to a sharp decrease in k cat , resulting in a neartotal loss of activity. Overall, the variant R197A had a 960-fold decrease in efficiency (k cat /K M ) from the wild-type, and R197K had a 690-fold decrease in k cat /K M . These decreases are in the same range as those observed previously for these mutations (33) .
In the case of the wild-type enzyme made by native chemical ligation (SrtA syn), there was a clear decrease in activity compared with the fully-recombinant wild-type enzyme (SrtA rec). k cat was decreased by 1.6-fold in SrtA syn, and K M was increased slightly, leading to an overall 2.1-fold decrease in k cat /K M for this enzyme. Native chemical ligation was performed under denaturing conditions (6 M GuHCl), following which the protein was refolded, and therefore it is not surprising that these harsh conditions caused a loss of some activity in SrtA syn. For the mutant R197Cit, which was also generated by native chemical ligation, we therefore compared the kinetics of the mutant with SrtA syn, rather than SrtA rec, to control for the effects of the native chemical ligation reaction.
R197Cit was found to be active, and the kinetics were similar to those of SrtA syn. The mutant R197Cit had a small decrease in k cat (2.3-fold lower than that of SrtA syn), and a negligible increase in K M , for an overall 2.8-fold decrease in k cat /K M . These data argue against an electrostatic interaction between Arg197 and the substrate. If an electrostatic interaction were important (either for substrate binding or for stabilizing the formation of an oxyanion-like transition state), then citrulline, which carries no formal positive charge, would be a poor substitute for arginine. Indeed, mutation of Arg197 to lysine, which carries a positive charge, resulted in a 690-fold decrease in k cat /K M .
Citrulline, unlike lysine, accurately mimics the steric shape of arginine. It is also capable, like arginine, of forming hydrogen bonds via its terminal -NH 2 group. Therefore the fact that the R197Cit mutant leads to such small decreases in SrtA activity is strong evidence for a hydrogenbonding role for Arg197. Given that the effect of the R197Cit mutant (as well as the other Arg197 mutants) is predominately on k cat and not K M , the hydrogen bond is likely not important for the initial SrtA-LPXTG binding event. Rather, the Arg197 hydrogen-bond is more likely playing a role by orienting the substrate in such a manner as to bring the catalytic residues (Cys184 and His120) into proper alignment for substrate cleavage.
Comparative structural analysis of SrtA N59 . Given the inconsistencies encountered between the existing X-ray crystal structures of SrtA N59 and the mutagenesis data obtained in this study and others, we turned to the original NMR structural model of SrtA N59 (PDB: 1IJA) (39) . Although NMR structures are generally of lower resolution than X-ray crystal structures, they often take into better account the flexibility of surface loops. Also, the NMR model was obtained in the presence of 20 mM CaCl 2 , whereas none of the X-ray structures were solved in the presence of calcium (28, 39) . Based on the above observations, we concluded that the NMR structure was a more appropriate model for the 6/ 7 loop of SrtA.
In order to compare the differences between the NMR model and the available X-ray structures, we selected two structures for comparison, which are shown in Figure 5 . On the left is shown the A chain from the X-ray structure of the LPETG-bound SrtA N59 C184A mutant (PDB: 1T2W). For ease of comparison, we have modeled a cysteine back in place of Ala184 in the active site. On the right is the NMR model of native SrtA N59 , which was determined in the presence of Ca 2+ , but in the absence of a LPETG peptide. Overall, the NMR model of SrtA is similar to the X-ray structure. Both structures take on the canonical "sortaselike" -barrel fold.
RMSD for -carbons between the two structures is a somewhat high 2.1 Å. However, within the "catalytic core" of -strands 1, 2, 4, 5, 6, 7, and 8, it falls to just 0.8 Å. The majority of the differences between the two structures lie in the conformation of surface-exposed loops. In particular, the 6/ 7 loops differ greatly between the two models, with an -carbon RMSD of 3.7 Å. Interestingly, in the NMR model the 6-7 loop is shifted closer to the active site, where the -carbon of residue Val168 is 3.1 Å closer to the -carbon of Cys184 in the NMR model relative to the X-ray structure, and that of Leu169 is 4.2 Å closer. The closer position of this loop leads to a more compact active site. For the NMR model, the active site cavity contains a volume of 456 Å 3 , compared with a cavity of 525 Å 3 in the X-ray structure.
In addition to the different position of the 6/ 7 loop, the orientation of several key side chains differs in the NMR model. Most strikingly, the side chain of Gln172, which pointed into the active site in the X-ray structure, is rotated up and away from the active site. Instead of being oriented to make a hydrogenbond to the backbone of the substrate LPETG peptide, it is now pointing out to solvent. Likewise, the orientation of Glu171 is altered from the X-ray structure; in the X-ray structure it pointed away from the active site, but in the NMR model it points towards the active site, and towards the putative calcium-binding site made up of residues Glu105, Glu108, Asp112, and Asn114 (29) . In both of these cases, the position of the side chain in the NMR model is more consistent with the biochemical data than the position observed in the X-ray structure.
Another important difference between the two structures is the relative position of Arg197. In the X-ray structure, it occupies a position far from the 6-7 loop, and is located relatively near to the catalytic Cys184. The distance from the -nitrogen of Arg197 to the -carbon of Val168 is 10.3 Å, whereas the distance to thesulfur of Cys184 is only 8.1 Å. Arg197 occupies an equivalent structural position in the NMR model. Since the 6/ 7 loop is shifted closer to the active site in this structure, it puts the -nitrogen of Arg197 only 4.9 Å from thecarbon of Val168, and it is now 10.0 Å from the -sulfur of Cys184 (see Figure 5 ). This relative repositioning places Arg197 in closer proximity to Val168 and Leu169, two residues that have been shown to be important for substrate recognition.
Taken together, the NMR model is more consistent with the available biochemical data than the existing X-ray structure, at least concerning the positioning of the 6/ 7 loop. This may reflect the fact that this loop is inherently flexible in SrtA (29, 39) , and together it highlights some of the limitations of X-ray crystal structures for functional information.
DISCUSSION
Alanine-scanning mutagenesis is a powerful tool for exploring the roles of specific residues in binding and catalysis. In our study, mutation of the hydrophobic residues Val168 and Leu169 resulted in 5.5 and 93-fold decreases in k cat /K M , respectively. These correspond to increases in the free energy of the transition state ( G ‡ ) of (46) . In the case of a leucine to alanine mutation, the loss of 3 methylene groups would be expected to add 2.1 kcal/mol to the free energy, close to the value observed for the L169A mutant. Similarly, the V168A mutation would be predicted to increase the free energy by 1.4 kcal/mol, close to our calculated value of 1.1 kcal/mol. Thus, the effects of our mutations are consistent with a model were Val168 and Leu169 both make hydrophobic interactions with the leucine of the substrate LPXTG sequence.
An expanded model for substrate recognition by SrtA. Recent studies have shed light on the molecular basis for substrate recognition in sortases, but many questions have remained unanswered. Although the importance of the 6/ 7 loop in LPXTG recognition has been established (29, 30) , the exact mechanism by which it does so has not been shown, nor have the contributions of individual residues within the 6/ 7 loop been investigated in a systematic way.
Additionally, the role of Arg197 in catalysis by SrtA has remained somewhat a mystery. A recent study was able to rule out a role for this residue in proton-transfer events, and suggested a role for Arg197 in stabilizing the formation of an oxyanion transition state (33); nonetheless, this study was unable to distinguish whether Arg197 acts via an electrostatic interaction or a hydrogen bond interaction.
In the current study, we have used a combination of alanine-scanning mutagenesis and steady-state kinetic measurements to explore the roles of six individual residues within the 6/ 7 loop. We have provided evidence that the LPXTG sorting signal of potential SrtA substrates is recognized primarily by hydrophobic interactions between residues Val168 and Leu169, which interact with the bulky, apolar Leu-Pro residues of the sorting signal. While Val168 and Leu169 have previously been suggested as potential recognition sites, to our knowledge this study is the first to directly show evidence for the importance of these hydrophobic residues.
Additionally, we have provided evidence which argues that residue Gln172 does not make a critical hydrogen-bonding interaction with the substrate. Finally, we have used a native chemical ligation strategy to generate the semisynthetic mutant R197Cit, and used this to provide evidence against the existence of an electrostatic interaction involving Arg197 during substrate recognition.
Taken together, these results are consistent with an expanded model for LPXTG recognition and cleavage based on a reverse protonation catalytic mechanism (47) . LPXTG-containing substrates are recognized primarily by van der Waals interactions between the bulky, hydrophobic Leu-Pro residues and the sidechains of Val168 and Leu169. Meanwhile, the bound conformation is stabilized via a hydrogen bond from Arg197. While the exact position of this hydrogen bond cannot be determined from our results, one possible site would be the backbone carbonyl between the proline and the X position of the LPXTG motif. Alternatively, Arg197 could hydrogen bond with the carbonyl of the scissile Thr-Gly bond and thus stabilize the oxyanion transition state of the enzyme. It remains unclear whether this hydrogen bond is utilized by the enzyme solely to position the substrate within the active site, or if it also acts to facilitate a distortion of the geometry of the peptide substrate in preparation for catalysis. Regardless, these interactions collectively combine to stabilize a specific LPXTG-bound conformation of the substrate, very likely in an activated form for catalysis.
Once bound, cleavage of the substrate is achieved through a reverse protonation mechanism as described previously (47 
FIGURE LEGENDS
Figure 1: X-ray structure of the LPETG-bound SrtA N59 C184A active-site. X-ray crystal structure of the active site of S. aureus SrtA N59 C184A (PDB: 1T2W, chain A), with a LPETG peptide bound in the active site. For clarity, we have modeled a cysteine back in place of Ala184. Although there were three molecules in the asymmetric unit, this model (chain A) is the only one which bound a LPETG peptide. This model shows the relative positions of the 3/ 4 (blue), 6/ 7 (red), and 7/ 8 (green) loops. Also shown are the side chains of the 6/ 7-loop residues Gly167-Gln172. A putative calciumbinding site (coordinated by Glu105, Glu108, Asp112, and Asn114) is indicated by the arrow. The peptide LPETG is shown in yellow. Catalytic residues His120 and Cys184 of SrtA are shown for reference, as is Arg197. Table 2 . Each data point was collected as the average signal over 20 sec, following a 30 sec equilibration at each temperature. . Top: The X-ray crystal structure of LPETGbound SrtA N59 C184A (PDB: 1T2W, chain A) is shown alongside an NMR model of native, unliganded SrtA N59 (PDB: 1IJA). For ease of comparison, a cysteine has been modeled back in place of Ala184 in the X-ray structure. Note the different backbone conformation of the 6/ 7-loops in the two models. In the NMR model, the C atoms of Val168 and Leu169 are 3.1 Å and 4.2 Å closer to Cys184 than in the Xray structure, respectively. The LPETG peptide from the X-ray structure is shown in stick format, for reference. Bottom: Space-filling models of the X-ray and NMR structures of SrtA N59 , highlighting the smaller active site of the NMR model (456 Å 3 , compared with 525 Å 3 in the X-ray structure). 
